Skip to main content
. 2022 Dec 3;14(12):2706. doi: 10.3390/pharmaceutics14122706

Figure 2.

Figure 2

The timeline of receptor tyrosine kinase inhibitor (RTKI) development and approval for the treatment of cancer. Adapted from [31], Copyright 2020 MDPI.